Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Mini Rev Med Chem ; 14(12): 988-1020, 2014.
Artigo em Inglês | MEDLINE | ID: mdl-25373848

RESUMO

4,5,6,7-Tetrahydrothieno pyridine is an important class of heterocyclic nucleus. Various 4,5,6,7-tetrahydrothieno pyridine derivatives have been synthesized and evaluated for various biological activities in different models with desired findings. Some analogs have shown potent biological activities and may be considered as lead molecule for the development of future drugs. Number of drug molecules are available in the market and many molecules are in clinical development containing 4,5,6,7-tetrahydrothieno pyridine nucleus as an important core. This review is an attempt to organize the chemical and biological aspects of 4,5,6,7-tetrahydrothieno pyridine analogs reported in last 20 year to till date. Review mainly focuses on the important role of the core in synthesis of drug or drug intermediates giving emphasis on synthetic schemes and biological activities of the different 4,5,6,7-tetrahydrothieno pyridine analogs.


Assuntos
Descoberta de Drogas , Piridinas/química , Piridinas/farmacologia , Animais , Antiarrítmicos/síntese química , Antiarrítmicos/química , Antiarrítmicos/farmacologia , Anti-Infecciosos/síntese química , Anti-Infecciosos/química , Anti-Infecciosos/farmacologia , Anti-Inflamatórios/síntese química , Anti-Inflamatórios/química , Anti-Inflamatórios/farmacologia , Antineoplásicos/síntese química , Antineoplásicos/química , Antineoplásicos/farmacologia , Antiprotozoários/síntese química , Antiprotozoários/química , Antiprotozoários/farmacologia , Arritmias Cardíacas/tratamento farmacológico , Bactérias/efeitos dos fármacos , Infecções Bacterianas/tratamento farmacológico , Fungos/efeitos dos fármacos , Humanos , Leishmania donovani/efeitos dos fármacos , Leishmaniose Visceral/tratamento farmacológico , Micoses/tratamento farmacológico , Neoplasias/tratamento farmacológico , Inibidores da Agregação Plaquetária/síntese química , Inibidores da Agregação Plaquetária/química , Inibidores da Agregação Plaquetária/farmacologia , Piridinas/síntese química
2.
Expert Opin Drug Deliv ; 7(10): 1227-34, 2010 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-20731614

RESUMO

IMPORTANCE OF THE FIELD: Most of the drugs that have been invented are of BCS Class II. Therefore, dissolution rate enhancement is the key aspect for absorption of these drugs. Liquisolid technology is very efficient in the dissolution rate enhancement of these drugs. Moreover, use of other polymers such as Eudragit and hydroxypropyl methylcellulose in the liquisolid approach can cause sustained release of drugs. This review focuses on the formulation approaches of liquisolid tablets or compacts along with its fundamental principles. AREAS COVERED IN THIS REVIEW: The review focuses on the developments in liquisolid technology from 1998 to 2009 with in vitro and in vivo performance of the dosage forms prepared using this technology. WHAT THE READER WILL GAIN: Benefits of this review include a concise evaluation of this technology by focusing on the scope of future developments to be done using this technique. TAKE HOME MESSAGE: Liquisolid technology, the next generation of powder solution technology, can be helpful for enhancing dissolution rates of poorly water-soluble drugs as well as effective at sustaining drug release.


Assuntos
Preparações de Ação Retardada/farmacologia , Desenho de Fármacos , Estabilidade de Medicamentos , Animais , Cães , Portadores de Fármacos , Masculino , Camundongos , Pós , Projetos de Pesquisa , Solubilidade , Solventes , Comprimidos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...